European Growth Stocks Insiders Are Banking On
Amidst the recent volatility in European equities driven by escalating Middle East tensions and fluctuating energy prices, investors are increasingly focusing on growth stocks with substantial insider ownership. In a market where inflation concerns and monetary policy decisions weigh heavily, companies where insiders have significant stakes can signal confidence in long-term potential, making them attractive considerations for those navigating these uncertain times.
Top 10 Growth Companies With High Insider Ownership In Europe
| Name | Insider Ownership | Earnings Growth |
| Pharma Mar (BME:PHM) | 12.1% | 39.8% |
| MilDef Group (OM:MILDEF) | 10.3% | 32.5% |
| Kuros Biosciences (SWX:KURN) | 25.9% | 58.6% |
| KebNi (OM:KEBNI B) | 16.3% | 103.8% |
| Gold Road International (OB:GOLDR) | 35.9% | 89.8% |
| Clavister Holding AB (publ.) (OM:CLAV) | 20.5% | 41.1% |
| CD Projekt Red (WSE:CDR) | 35.2% | 50.1% |
| Bonesupport Holding (OM:BONEX) | 10.6% | 32.2% |
| Bergen Carbon Solutions (OB:BCS) | 11.9% | 52% |
| 2G Energy (XTRA:2GB) | 13.4% | 29.8% |
Here we highlight a subset of our preferred stocks from the screener.
Nordic Semiconductor (OB:NOD)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Nordic Semiconductor ASA is a fabless semiconductor company that offers low power wireless connectivity solutions across Europe, the Americas, and the Asia Pacific, with a market cap of NOK37.05 billion.
Operations: The company's revenue primarily comes from the design and sale of integrated circuits and related solutions, totaling $759.48 million.
Insider Ownership: 10.4%
Nordic Semiconductor has demonstrated strong growth, with recent earnings up significantly compared to last year. The company reported a net income of US$16.43 million for Q2 2026, reflecting robust financial performance. While insider trading activity over the past three months is not substantial, the company's earnings are forecast to grow at 37% annually, outpacing the Norwegian market's average. Revenue growth is also expected to exceed market averages despite being below 20% annually.
- Click here and access our complete growth analysis report to understand the dynamics of Nordic Semiconductor.
- Our expertly prepared valuation report Nordic Semiconductor implies its share price may be too high.
HMS Networks (OM:HMS)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: HMS Networks AB (publ) offers industrial information and communication technology solutions globally, with a market cap of SEK27.98 billion.
Operations: The company's revenue is derived from three segments: New Industries (SEK848.09 million), Industrial Data Solutions (SEK1.78 billion), and Industrial Networks Technology (SEK1.18 billion).
Insider Ownership: 12.3%
HMS Networks has demonstrated solid financial performance, with Q2 sales reaching SEK 991 million and net income rising to SEK 155 million. Earnings per share increased significantly from the previous year. Although revenue growth is forecast at 10.8% annually, it surpasses the Swedish market average. Insider buying activity is present but not substantial, while earnings are expected to grow significantly at over 21% annually despite a high level of debt.
- Navigate through the intricacies of HMS Networks with our comprehensive analyst estimates report here.
- Our valuation report unveils the possibility HMS Networks' shares may be trading at a premium.
Medicover (OM:MCOV B)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Medicover AB (publ) offers healthcare and diagnostic services in Poland, Sweden, and internationally, with a market cap of SEK39.36 billion.
Operations: The company's revenue is primarily derived from Healthcare Services, which generated €1.71 billion, and Diagnostic Services, contributing €789.10 million.
Insider Ownership: 11.5%
Medicover's earnings are forecast to grow significantly at 21.1% annually, outpacing the Swedish market. Despite a low future return on equity of 16.7%, the company trades below estimated fair value, suggesting potential upside. Recent insider activity shows more shares sold than bought in the past three months, indicating possible concerns. The divestment of Medicover Hospitals India to KKR could impact future financials, while recent earnings reported growth with sales reaching €640.4 million for Q2 2026.
- Take a closer look at Medicover's potential here in our earnings growth report.
- The analysis detailed in our Medicover valuation report hints at an inflated share price compared to its estimated value.
Turning Ideas Into Actions
- Investigate our full lineup of 213 Fast Growing European Companies With High Insider Ownership right here.
- Seeking Other Investments? Uncover 27 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com